Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and lifestyle intervention to prevent androgen deprivation therapy-related metabolic syndrome in prostate cancer
2007-002815-20Phase 2Unknown
- Sponsor
- Royal Surrey County Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin in prostate cancer (PCa) (2 arms), sponsored by Royal Surrey County Hospital. Primary endpoints: Incidence of hyperglycaemia after 6 months and Incidence of abdominal obesity after 6 months. Status: unknown.
02
Drugs
metformin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2007-002815-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002815-20.